<i>In vivo</i> detectability of tau‐PET tracers in Alzheimer’s disease

Tau-PET tracers exhibit significant variability in detectability. [<sup>18</sup>F]MK6240 consistently demonstrated lower NRR, implying better detectability across all regions, cross-sectionally and longitudinally. Despite differences in NRR, [<sup>18</sup>F]FTP, [<sup>18</sup>F]RO948 and [<sup>18</sup>F]PI2620 followed similar pattern. These results provide insights into the differential tracer detectability, helping guide their optimal use in detecting and tracking tau pathology. Ongoing follow-up scans will further clarify longitudinal tracer detectability and its implications for tau progression in AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70862_109804
Primary Topic
Medical Imaging Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vivo detectability of tau‐PET tracers in Alzheimer’s disease

Val J. Lowe, Tharick Ali Pascoal, Nesrine Rahmouni, Belén Pascual et al.
Alzheimer s & Dementia
Medical Imaging Techniques and Applications
article

In vivo detectability of tau‐PET tracers in Alzheimer’s disease

Val J. Lowe, Tharick Ali Pascoal, Nesrine Rahmouni, Belén Pascual, Arthur C. Macedo, Suzanne L. Baker, Firoza Zubeida Lussier, Jacob Ziontz, Pedro Rosa‐Neto, David Soleimani‐Meigooni, Hsin‐Yeh Tsai, Cécile Tissot, Jenna Stevenson, Hwamee Oh, Lydia Trudel, William J. Jagust, Joseph Therriault, Brian A. Gordon, Peiwei Liu, Stijn Servaes, William E Klunk
article en

Abstract

Tau-PET tracers exhibit significant variability in detectability. [<sup>18</sup>F]MK6240 consistently demonstrated lower NRR, implying better detectability across all regions, cross-sectionally and longitudinally. Despite differences in NRR, [<sup>18</sup>F]FTP, [<sup>18</sup>F]RO948 and [<sup>18</sup>F]PI2620 followed similar pattern. These results provide insights into the differential tracer detectability, helping guide their optimal use in detecting and tracking tau pathology. Ongoing follow-up scans will further clarify longitudinal tracer detectability and its implications for tau progression in AD.

Alzheimer s & DementiaVol. 21(S8)
Houston Methodist (US), Lawrence Berkeley National Laboratory (US), University of Pittsburgh (US), University of California, San Francisco (US), Washington University in St. Louis (US), Brown University (US), Mayo Clinic in Arizona (US), McGill University (CA), University of California, Berkeley (US)
Openalex Percentile: Top 31%
Medical Imaging Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.